How Suction Thrombectomy Works to Clear Blood Clots

Suction thrombectomy is a minimally invasive procedure that uses vacuum pressure delivered through a catheter to physically pull blood clots out of blocked vessels. Rather than dissolving a clot with drugs, a doctor threads a thin tube through the vascular system to the site of the blockage and applies suction to extract the clot in one or several passes. The technique has become a frontline treatment for strokes caused by large vessel blockages and is increasingly used to clear clots in the lungs, legs, and deep veins. Its rapid adoption over the past decade reflects a shift in how clinicians think about clot removal: instead of waiting for a drug to work, you go in and physically take the clot out.

How Suction Pulls a Clot Free

The basic physics are deceptively simple. A vacuum source generates negative pressure, and a catheter transmits that pressure to the clot face. But the force the clot actually feels depends less on how strong the vacuum is and more on how large the catheter opening is. Lab testing of various catheters and pump systems found that all commercially available devices transmit similar vacuum pressures, but the suction force on the clot scales proportionally with the area of the catheter tip.¹ A wider-bore catheter means more force on the clot, which is why the field has steadily moved toward larger aspiration catheters.

The vacuum source itself matters less than you might expect. Dedicated mechanical pumps, handheld aspiration devices, and even a standard 60-mL syringe all produce comparable vacuum pressures.² What separates one system from another is mostly ergonomics, ease of use, and how the catheter itself navigates the anatomy to reach the clot. That navigability is the real engineering bottleneck: the bigger the catheter tip, the harder it is to steer through twisting blood vessels, especially the tight curves of the brain’s internal carotid artery.

One wrinkle is how suction is applied. A proof-of-concept study found that cycling the vacuum on and off outperformed constant static suction for overall clot removal and removal speed.³ Pulsing the vacuum may help dislodge the clot from the vessel wall more effectively than a steady pull, though this finding has not yet been universally adopted into clinical practice.

Stroke Treatment and the ADAPT Technique

The most prominent use of suction thrombectomy is for acute ischemic stroke, specifically the type caused when a large artery in the brain becomes blocked by a clot. The approach known as ADAPT, for A Direct Aspiration First-Pass Technique, navigates a large-bore aspiration catheter directly to the clot and attempts to suck it out in a single pass before resorting to other methods. Multiple observational studies have suggested that ADAPT is at least as effective as the main alternative, stent retrievers, for reopening blocked brain arteries.⁴

A systematic review and meta-analysis of ADAPT studies found that the technique achieved successful reopening of the blocked vessel about two-thirds of the time on its own. When a rescue stent retriever was brought in for the remaining cases, the combined success rate climbed to roughly nine in ten patients. About half of patients treated with ADAPT achieved functional independence at 90 days, with a mortality rate around 15% and symptomatic brain bleeding in about 5% of cases.⁵ Those numbers reflect a devastating disease where, without any intervention, outcomes are far worse.

Aspiration Versus Stent Retrievers

The comparison between aspiration-based thrombectomy and stent retrievers has been the central debate in stroke intervention over the past decade. Stent retrievers work differently: a mesh device is deployed inside the clot, which becomes enmeshed in the stent, and then the whole assembly is pulled back out. Both approaches have amassed large bodies of evidence, and the honest summary is that they produce broadly similar clinical outcomes.

A meta-analysis pooling over 9,000 patients found that successful reopening rates were actually higher in the aspiration group than the stent retriever group, at roughly 89% versus 80%. But that gap in vessel reopening did not translate into statistically significant differences in the outcomes that matter most to patients: functional independence at three months, symptomatic brain bleeding, or mortality.⁶ A separate meta-analysis similarly found no significant difference in clinical outcomes between ADAPT and stent retrievers, though patients in the aspiration group needed rescue therapy more often.⁷

The ASTER trial, a randomized head-to-head comparison, reinforced these findings. Successful revascularization occurred in about 85% of the aspiration group and 83% of the stent retriever group, a difference that was not statistically meaningful.⁸ For blockages in the basilar artery at the back of the brain, aspiration and stent retriever thrombectomy also showed no significant difference in functional outcomes, though procedure time was shorter with aspiration (a median of 32 versus 47 minutes) and mortality trended lower in the aspiration group.⁹

The practical upshot is that neither technique is clearly superior. Many centers now choose based on operator experience, clot location, and patient anatomy, and increasingly, they combine both methods.

Combining Aspiration and Stent Retrieval

Rather than picking one approach, clinicians have experimented with deploying aspiration and stent retrievers simultaneously. The rationale is intuitive: the stent grabs the clot while suction holds it in place, reducing the chance that fragments break off and float downstream. The ASTER2 trial tested this head-to-head. After the assigned first attempt alone, the combined approach achieved a higher rate of successful blood flow restoration than the stent retriever by itself. The improvement was modest but statistically meaningful for the broader measure of reperfusion.¹⁰ By the end of the full procedure (which allowed additional passes and technique switching), the top-tier reperfusion rate was numerically higher in the combination group but no longer reached statistical significance. The evolution of stroke thrombectomy has generally moved toward combination approaches and toward balloon guide catheters that temporarily arrest blood flow, both of which appear to reduce the chance that clot fragments escape into previously unaffected territory.¹¹

Why Getting the Clot on the First Pass Matters

A concept that has gained traction in the thrombectomy world is the “first-pass effect,” meaning whether the clot is successfully removed on the very first attempt. This is not merely an efficiency metric. A meta-analysis found that patients who achieved complete or near-complete reopening on the first pass had significantly better outcomes: about 56% achieved functional independence at 90 days compared with 41% in patients who required multiple passes. Mortality was also lower, at 17% versus 25%.¹² A separate meta-analysis confirmed the pattern, finding that first-pass success was independently associated with better 90-day outcomes and lower mortality.¹³

Each additional pass through the vessel risks damaging the artery, dislodging fragments downstream, and extending procedure time during which brain tissue is dying. This is one reason catheter design has focused so intently on maximizing the suction force and catheter tip area: a bigger, more effective first bite at the clot may spare the patient several rounds of attempts.

Complications and Risks

Suction thrombectomy is not risk-free. The most feared complication during any thrombectomy procedure is distal embolization, where fragments of the clot break off and travel further downstream to block smaller vessels. In one study of anterior-circulation strokes, distal embolization was documented in about 28% of patients. Longer clots on initial imaging predicted higher embolization risk, but the specific thrombectomy technique used (aspiration versus stent retriever) was not significantly associated with this complication.¹⁴ Distal embolization is not unique to suction-based methods. A case report involving the AngioVac suction device described a scenario where a large thrombus could not be fully aspirated, leading to fragmentation and hemodynamic collapse.¹⁵ Such events are uncommon but underscore that the technique carries inherent risks when dealing with large or firm clots.

Vessel perforation is rarer but far more dangerous. A multicenter study of vessel perforations during thrombectomy found 90-day mortality of about 52% in patients who experienced this complication, with only about 16% achieving functional independence.¹⁶ Perforation remains uncommon overall, but it is the complication that keeps interventionalists most cautious about device selection and technique, particularly in tortuous anatomy.

Beyond the Brain: Pulmonary Embolism

Suction thrombectomy has expanded well beyond stroke. One of its fastest-growing applications is in pulmonary embolism, where a large clot lodges in the arteries feeding the lungs. Traditional treatment relies on blood-thinning drugs or clot-dissolving medications, but for patients with massive or high-risk PE, waiting for drugs to work can be dangerous. Large-bore aspiration devices allow clinicians to physically vacuum the clot out of the pulmonary arteries through a catheter inserted via a vein in the groin or neck.

An early series using the FlowTriever device reported technical success in 100% of cases, with average pulmonary artery pressure dropping significantly after the procedure. Every patient survived to hospital discharge, and about 71% saw their oxygen requirements improve during the procedure itself. Major adverse events occurred in about 5% of patients.¹⁷ Separate experience with aspiration thrombectomy for massive and submassive PE confirmed the approach as a feasible option for patients with compromised heart function or unstable blood pressure.¹⁸ The PE indication has driven significant industry investment, with several dedicated catheter systems now competing in this space.

Legs, Veins, and Limb Salvage

When a clot blocks an artery in the leg, the result is acute limb ischemia, a condition where tissue starts dying from lack of blood flow. Historically, treatment meant open surgery to cut out the clot or prolonged infusion of clot-dissolving drugs directly into the artery. Suction thrombectomy offers a middle path. The STRIDE study, using the Indigo aspiration system, found that aspiration thrombectomy achieved a 98% rate of limb salvage at 30 days with few complications.¹⁹ At one year, limb salvage remained high at about 89%, and patients reported meaningful improvements in quality of life across all measured domains.²⁰

Lab results using vacuum-assisted thrombectomy for acute limb ischemia showed that clots below the knee were cleared more successfully than those above it, and above-the-knee blockages more often needed additional balloon or stent procedures to finish the job.²¹ The takeaway is that suction works well for smaller vessels but may need to be supplemented with other tools in larger arteries where clots tend to be bulkier and more adherent.

On the venous side, deep vein thrombosis in the legs and pelvis can also be treated with aspiration. Manual aspiration thrombectomy has been described as a rapid alternative to open surgical thrombectomy with comparable effectiveness and minimal risk.²² In a series of patients with acute deep vein thrombosis in the iliac and femoral veins treated with a dedicated aspiration system, symptom improvement was universal before discharge, though technical success on imaging was more variable, and a modification using a snare device instead of the standard separator significantly improved results.²³

Thrombectomy Versus Clot-Dissolving Drugs Alone

For stroke, the evidence is now clear that endovascular thrombectomy (including aspiration-based approaches) outperforms intravenous clot-dissolving medication used alone. A network meta-analysis found that direct mechanical thrombectomy was associated with roughly 41% higher odds of functional independence and 60% higher rates of successful vessel reopening compared with the standard drug, tPA, given by itself.²⁴ One trial directly comparing aspiration thrombectomy after tPA versus tPA alone was halted early because external evidence had already demonstrated the benefit of adding endovascular treatment; within the trial itself, all secondary measures consistently favored the aspiration group.²⁵ Today, in patients with large vessel occlusion strokes, thrombectomy is standard of care. The question is no longer whether to perform it, but which technique and combination to use.

What Predicts Success

Not all clots respond equally well to suction. Research using CT imaging has shown that a property called clot perviousness, essentially how porous the clot is to contrast dye, predicts whether aspiration will succeed on the first pass. In the COMPASS trial, clots with higher perviousness were significantly more likely to be cleared on the initial aspiration attempt. Using a statistical cutoff, high perviousness independently predicted first-pass success with nearly fourfold higher odds. This relationship held specifically for aspiration thrombectomy but not for stent retriever techniques.²⁶ A porous clot is likely softer and more deformable, making it easier for the catheter to latch on and extract. Hard, calcified clots or those with heavy fibrin composition tend to resist suction and may fragment instead.

Beyond clot characteristics, long-term outcomes after thrombectomy depend heavily on patient factors. Age under 70, milder stroke severity at admission, low neurological deficits 24 hours after the procedure, and achieving complete reopening of the artery were all independent predictors of favorable long-term outcome. Early infection requiring treatment within the first 72 hours was a strong negative predictor.²⁷

Cost and Accessibility

Thrombectomy is expensive. The devices themselves, the specialized angiography suite, and the team of neurointerventionalists or interventional radiologists required all drive costs higher than medical management alone. But systematic review data suggest that endovascular therapy is cost-effective when judged by standard thresholds, because the reduction in long-term disability offsets the upfront expense.²⁸ A stroke patient who walks out of the hospital independently does not need years of institutional care.

Device costs vary considerably across systems. A recent cost-effectiveness comparison found that device costs for a newer single-catheter system averaged around $7,800, compared with about $10,000 for conventional aspiration and over $19,000 for combined stent-and-aspiration setups. Total costs followed the same pattern.²⁹ For deep vein thrombosis in the legs, adding mechanical thrombectomy to standard blood-thinning treatment costs roughly $170 per additional percentage point of treatment efficacy, a relatively modest premium for meaningfully better clot clearance.³⁰

The bigger access barrier is not cost but geography. Thrombectomy requires specialized operators and equipment, which remain concentrated in urban medical centers. Patients in rural areas often face long transfer times that eat into the narrow window when treatment is most effective.

Where Catheter Design Is Headed

The central tension in aspiration catheter engineering is the trade-off between bore size and navigability. Larger tips grip clots more effectively, but wider, stiffer catheters are harder to steer through winding arteries. Newer large-bore aspiration catheters have addressed this by improving trackability, torque response, and tip flexibility so they can navigate challenging anatomy like the tight curves of the carotid siphon without sacrificing suction area.³¹

More experimental concepts are pushing further. One research group has designed a magnetically steerable catheter whose tip can expand in diameter once it reaches the clot site, using external magnetic fields for both navigation and expansion. The idea is to thread a thin, flexible catheter through tight anatomy and then widen it at the target to maximize suction force.³² On the computational side, researchers are using fluid dynamics simulations to optimize catheter tip geometry. Work on venturi-style tapered tips found that a 45-degree taper angle was optimal for extraction speed, but steeper tapers came with a trade-off: more clot fragmentation. A 60-degree taper produced more than twice the fragments of a 30-degree design.³³ Alternative catheter geometries, like hole-pattern designs along the catheter shaft, have been explored through computer simulation to increase suction force while reducing the stress on the clot that causes it to break apart.³⁴ The theme across all these efforts is the same: get more force on the clot while keeping it intact, because every fragment that breaks off becomes a new downstream blockage.